Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10Stomach Neoplasms 5Colonic Neoplasms 5Carcinoma, Hepatocellular 4Rectal Neoplasms 3Pancreatic Neoplasms 2Neoplasms 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Biliary Tract Neoplasms 2Vipoma 1Somatostatinoma 1Resected Liver Metastases From Colorectal Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Complete Response 1Neutropenia 1Neuroendocrine Tumors 1Malignant Tumor of Pancreas Metastatic to Liver 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia 1Insulinoma 1Glucagonoma 1Gestational Trophoblastic Disease 1Gastrinoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Diarrhea 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Islet Cell 1

Interventions

Loperamide 1Leucovorin 1Irinotecan 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Diarrhea × Leucovorin × Clear all
NCT01523431 2017-03-30

Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Phase 2/3 Completed
583 enrolled
Gastrointestinal

Diarrhea, Neutropenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡